Abstract
Purpose
For somatostatin receptor (SSTR)-positron emission tomography/computed tomography (PET/CT), a standardized framework termed SSTR-reporting and data system (RADS) has been proposed. We aimed to elucidate the impact of a RADS-focused training on reader’s anxiety to report on SSTR-PET/CT, the motivational beliefs in learning such a system, whether it increases reader’s confidence, and its implementation in clinical routine.
Procedures
A 3-day training course focusing on SSTR-RADS was conducted. Self-report questionnaires were handed out prior to the course (Pre) and thereafter (Post). The impact of the training on the following categories was evaluated: (1) test anxiety to report on SSTR-PET/CT, (2) motivational beliefs, (3) increase in reader’s confidence, and (4) clinical implementation. To assess the effect size of the course, Cohen’s d was calculated (small, d = 0.20; large effect, d = 0.80).
Results
Of 22 participants, Pre and Post were returned by 21/22 (95.5%). In total, 14/21 (66.7%) were considered inexperienced (IR, < 1 year experience in reading SSTR-PET/CTs) and 7/21 (33.3%) as experienced readers (ER, > 1 year). Applying SSTR-RADS, a large decrease in anxiety to report on SSTR-PET/CT was noted for IR (d = − 0.74, P = 0.02), but not for ER (d = 0.11, P = 0.78). For the other three categories motivational beliefs, reader’s confidence, and clinical implementation, agreement rates were already high prior to the training and persisted throughout the course (P ≥ 0.21).
Conclusions
A framework-focused reader training can reduce anxiety to report on SSTR-PET/CTs, in particular for inexperienced readers. This may allow for a more widespread adoption of this system, e.g., in multicenter trials for better intra- and interindividual comparison of scan results.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
The demand for somatostatin receptor (SSTR) imaging with subsequent therapy for neuroendocrine neoplasms (NEN) has rapidly expanded in recent years [1,2,3], mainly due to encouraging results of the first randomized, controlled trial demonstrating the efficacy and safety of SSTR-targeted peptide receptor radionuclide therapy (PRRT) [4,5,6]. To conduct such treatment, uptake in putative sites of disease should be confirmed by a preceding SSTR-directed positron emission tomography (PET)/computed tomography (CT) scan [7, 8], and a precise interpretation of such scans is of utmost importance to select appropriate treatment candidates or to risk-stratify patients [9, 10].
NEN are a very rare and heterogenous tumor entity and therefore — outside of specialized centers — nuclear medicine professionals do not have much routine in the interpretation of SSTR-PET/CT in NEN [11, 12]. Lack of experience with this orphan disease is most likely associated with test anxiety and perceived stress for the interpreting nuclear medicine professional. For instance, in conventional radiology, increased stress caused by diagnostic errors can trigger a vicious circle leading to even more false findings [13, 14]. Nonetheless, a correct scan interpretation is vital for the referring oncologist to initiate the most appropriate therapeutic strategy in patients affected with NEN. As such, in order to minimize stress and anxiety in inexperienced readers (IRs), molecular imaging has to advance their training models and provide guiding tools that determine precisely what makes abnormalities different from normal tissue [15].
Partly as a result, the American College of Radiology has established numerous reporting and data systems (RADS) to enable standardized reporting on imaging findings in a wide variety of diagnostic settings [16]. In analogy to the similarities of different RADS systems for specific organs such as TI-RADS for thyroid or LI-RADS for liver [17, 18], a standardized framework for SSTR-PET/CT termed SSTR-RADS was introduced [19]. SSTR-RADS is based on a 5-point scale (from 1 = no evidence of disease and definitively benign to 5 = high certainty that NEN is present), and is predicated upon the site and intensity of radiotracer uptake [19]. A recent study demonstrated that SSTR-RADS may be useful to identify patients eligible for PRRT [20]. Moreover, a high interobserver agreement rate for SSTR-RADS on scan interpretation was also observed, even among readers with less experience in reading SSTR-PET/CTs [21] and therefore, one may speculate that such a standardized framework system is readily applicable for larger clinical trials or clinical routine in a busy PET/CT practice.
However, little is known on the impact of such a standardized framework on reader’s anxiety to report on SSTR-PET/CTs, the motivational beliefs in learning such a system, whether it increases reader’s confidence, or its implementation in clinical routine. Organized by the European School of Multimodality Imaging and Therapy (ESMIT), a 3-day training course focusing on SSTR-RADS for nuclear medicine professionals was conducted, which allowed the participants to apply SSTR-RADS in a practical manner. Using dedicated questionnaires, we aimed to elucidate the impact of this RADS-focused educational intervention on test anxiety, the motivation to learn SSTR-RADS, the change in level of confidence when applying SSTR-RADS, and the rate of clinical implementation by participants at their home institutions.
Materials and Methods
Training
This project was approved by the ESMIT of the European Association of Nuclear Medicine (EANM). All training participants gave written informed consent to participate in this study (including follow-up via email). In May 2018, a 3-day training focusing on SSTR-directed imaging and therapy entitled “Theranostics – clinical and non-clinical aspects (radiopharmacy, physics, and dosimetry) of NENs” was conducted and hosted under the umbrella of the “ESMIT Spring School.” This track was rated as Level 2 within the ESMIT [22]. In brief, this course aimed to cover clinical aspects of molecular imaging and PRRT of NEN patients, while non-clinical topics related to patient management were also addressed. Clinical sessions focused on SSTR-RADS 1.0 [19], including an overview of the most common pitfalls and artifacts in interpreting SSTR-PET/CTs [19, 23, 24] (Table S1). In addition, multiple hands-on cases with different levels of difficulty including respective information on patient’s history were also presented. Provided scans were displayed on a dedicated workstation, thereby allowing to modify the uptake levels. First, participants familiarized themselves with a case displaying normal biodistribution. The second case included a pancreatic NET with a Ki67 of 5–10% and SSTR-RADS scores on a target-lesion level had to be provided by the participants (e.g., lesions classified as SSTR-RADS 1B, SSTR-RADS 4, or SSTR-RADS 5). This respective case was also eligible for SSTR-directed PRRT. Last, a patient afflicted with an atypical carcinoid was presented. On SSTR-PET/CT, the participants had to identify an SSTR-RADS 3D lesion in the lung. A respective [18F]-fluorodeoxyglucose PET/CT was then also displayed, revealing an intense uptake in the SSTR-negative (RADS 3D) lesion (“flip flop phenomenon”). This patient was then considered not eligible for PRRT.
Questionnaires and Measures
In total, three questionnaires were provided to the participants. The first questionnaire was handed out prior to the course (Pre), while the second questionnaire was handed out directly after the lectures (Post). Finally, a follow-up (FU) questionnaire was sent out 3 months later via email. Fig. S1 provides an overview of the study design. The participants indicated general information including primary place of work (academic institution or medical center), experience with SSTR-targeted imaging (< 1 year or > 1 year), and whether they perform PRRT at their home institution. All participants are referred to as all readers (AR) in the remainder of the manuscript. Participants were also categorized as IR having < 1 year experience in interpreting SSTR-PET/CTs and experienced readers (ER, > 1 year). All attendees responded to one of the following 12 questions (Q), which were modified from [25] and divided into four categories:
-
Q1–3, which included items on test anxiety to provide a written report on SSTR-PET/CT;
-
Q4–5, which referred to the motivation to learn a standardized reporting system for SSTR-PET/CT;
-
Q6–8, which measured the level of reader’s confidence for reading and interpreting SSTR-PET/CT;
-
Q9–12 evaluating the rate of implementation of a standardized framework for SSTR-targeted molecular imaging in clinical routine (Table 1).
Independent of the wording that was used, a 4-point Likert scale for self-reflection was provided for all 12 questions (i.e., the answers ranged from 1, “very untrue of me”; 2, “untrue of me”; 3, “true of me”; 4, “very true of me”). In addition, the Qs of all three questionnaires had identical content; however, the Qs in Post and FU have been slightly re-phrased to fit the current situation and timing prior to and after the course.
Participants and Return Rate of Questionnaires
Pre and Post were returned by 21/22 (95.5%). Due to the low response rate of FU (3/21 [14.3%]), this last questionnaire was removed from further analysis. The vast majority of respondents worked in an academic environment (17/21 [81%]), followed by a medical center (4/21 [19%]). In total, 14/21 (66.7%) were rated as IR, with the remaining 7/21 (33.3%) categorized as ER. And 14/20 (70%) indicated that they do not perform PRRT at their home institutions (with one participant not responding to this item).
Statistics
To allow for a category-based investigation, a combined analysis of the respective Qs allocated to one of the four categories was conducted. Therefore, to test the impact of the training on test anxiety, motivational beliefs, level of confidence, and implementation of SSTR-RADS in clinical routine, the mean scores of their corresponding items were calculated. Variables are expressed as mean ± standard deviation. Given four possible answers ranging from 1 to 4, the theoretical mean is as follows:
And therefore, 2.5 indicates neither approval nor disagreement. Consequently, values > 2.5 indicate approval, where values < 2.5 indicate disagreement. The 2-tailed paired Student’s t-test was used to compare pre-post values. Statistical analyses were performed in R (version 3.6.1, R Core Team, 2019). Evaluating the training-based impact, the effect size Cohen’s d was calculated (small, d = 0.20; medium, d = 0.50; large, d = 0.80) [26]. A P < 0.05 was considered statistically significant.
Results
SSTR-RADS-focused Training Can Reduce Test Anxiety of IR, but not ER
Analyzing Q1, Q2, and Q3, with emphasis on the change in test anxiety before and after the training, the change from pre to post on the 4-point Likert scale for AR was − 0.21 ± 0.65, thereby indicating a small to medium effect by the course (d = − 0.32, P = 0.16; Fig. 1A). However, this was driven by IR with a significant medium to large reduction in anxiety (change Pre to Post, − 0.36 ± 0.48; d = − 0.74, P = 0.02; Fig. 1B), while for ER, only an insignificant effect caused by the program was noted (change, 0.10 ± 0.85, d = 0.11; P = 0.78; Fig. 1C). This was also further corroborated on an intraindividual level. In total, 10/21 (47.6%) of AR demonstrated a reduction in test anxiety (Fig. 2A, green lines), from whom 9 (90%) were identified as IR (ER, 1/10 [10%]; Fig. 2B, C).
Throughout the Training, Participants were Motivated to learn SSTR-RADS
Analyzing Q4 and Q5, with an emphasis on change in motivation to learn a standardized framework, AR were motivated to learn RADS already prior to the course (Pre, 3.55 ± 0.50), which remained stable (Pre to Post decline, 0.14 ± 0.50; Fig. 1D). Consequently, for AR, only a small course-based effect on motivational beliefs was observed (d = − 0.28, P = 0.21). This was also independent of previous reading experience (IR, change Pre to Post, − 0.18 ± 0.37, d = − 0.48, P = 0.1; ER, − 0.07 ± 0.73, d = − 0.1, P = 0.81). On an intraindividual level, 2/21 (9.5%; Fig. 3A) reported on an increase in motivation (IR and ER, 1/2 [50%], respectively; Fig. 3B, C, green lines). However, already prior to training, 21/21 (100%) were motivated to learn SSTR-RADS (i.e., test score > 2.5; Fig. 3A) and a decline ≤ 2.5 (indicative for less motivation or indifference) was only noted in 2/21 (9.5%) individuals after the program.
Reader’s Confidence Remains High when Applying SSTR-RADS
Analyzing Q6, Q7, and Q8 to assess the change in reader’s confidence, AR already indicated prior to the intervention that their level of confidence is high when a standardized framework for SSTR-PET/CT is applied (Pre, 3.36 ± 0.48), which did not change throughout the training (− 0.06 ± 0.54), indicating a small course-based effect (d = − 0.11, P = 0.62; Fig. 1E). This was again independent of previous reading experience. IR indicated high approval rates when asked if SSTR-RADS can increase their level of confidence (Pre, 3.45 ± 0.48; change Pre to Post, 00 ± 0.40), with no impact due to the training (d = 0, P = 1; ER: change Pre to Post, − 0.18 ± 0.77; d = − 0.23, P = 0.56). On an intraindividual level, 6/21 (28.6%) demonstrated an increase in confidence (Fig. 4A, green lines; IR, 4/6 [66.7%], ER, 2/6 [33.3%]; Fig. 4B, C). However, already prior to the course, 20/21 (95.2%,) reported on a high level of confidence (test score > 2.5) (Fig. 4A) and a decline ≤ 2.5 (indicative for decline in the level of confidence or indifference) was only recorded in 2/20 (10%).
Throughout the Training, Rate of Clinical Implementation of SSTR-RADS Remains High
Analyzing Q9, Q10, Q11, and Q12 in order to assess the implementation of SSTR-RADS into clinical routine, AR noted already prior to the course that their rate of implementation is high (Pre, 3.30 ± 0.46), which did not change throughout the program (− 0.02 ± 0.57), corresponding to a small to non-existent effect size due to the training (d = − 0.03, P = 0.9; Fig. 1F). When responding to the questionnaire which was handed out prior to the course, IR (Pre, 3.29 ± 0.50) and ER (Pre, 3.33 ± 0.38) recorded that they are willing to use a framework for SSTR-PET/CT at their home institutions, which remained similar throughout the course (IR, 0.07 ± 0.42; ER, − 0.19 ± 0.81). Consequently, the effect size was rated as small for both IR (d = 0.17) and ER (d = − 0.23, P ≥ 0.53). On an intraindividual level, 9/21 (42.9%) demonstrated an increase in the rate of clinical implementation of SSTR-RADS at their departments (Fig. 5A). This was primarily driven by IR with an approval rate of 7/9 (77.8%; ER, 2/9 [22.2%]; Fig. 5B, C). Already prior to the course, 20/21 (95.2%) reported on a high level of confidence when SSTR-RADS is applied and a decline < 2.5 (indicative for less clinical implementation) was only noted in 1/20 (5%, red line; Fig. 5A).
Table S2 provides an overview of the Likert scale rating before and after the course and the respective changes (along with Cohen’s d) for AR. Table 2 provides respective information for IR and Table 3 for ER.
Discussion
Training on SSTR-RADS for SSTR-directed PET/CT led to a medium to large reduction of test anxiety in less experienced readers for providing scan reports. Motivation of attendees to learn a framework for PET/CT interpretation, their level of confidence, and rate of clinical implementation were already high prior to training (≥ 3.30 ± 0.46), independent of previous reading experience. In light of these increased pre-interventional test scores, analyses of Cohen’s d revealed a small effect (AR, range, d = − 0.32 to − 0.03), thereby suggesting that the impact of the provided training for these categories was low. Nonetheless, given the stable test scores after the intervention with an average decline for AR of only ≥ 0.02, one may speculate that participants are per se motivated to learn a framework for SSTR-directed imaging interpretation, are convinced that such a framework increases their confidence, and, lastly, are willing to implement RADS at their home institutions.
In general, test anxiety is situation-specific and highly depends on intraindividual differences to what extent an anxious individual experiences an examination as a threat [27]. This rather broad definition has been expanded by Zeidner defining multiple levels of test anxiety, including somatic symptoms such as palpitations or sweating, downgrading self-statements about (academic) failure, and behavioral avoidance tendencies such as procrastination [28, 29]. Of note, in an academic environment, increasing test anxiety was tightly linked to debilitating academic output [30] and therefore, one may speculate that an increasing concern about the written report of a scan may also hamper performance of the interpreting radiologist [31]. In the present study investigating the impact of a RADS-specific course on test anxiety in the context of SSTR-PET/CT reporting, an average decline of 0.36 points on a Likert-type scale was noted for IR (d = − 0.74, P = 0.02), but not for ER (d = 0.11, P = 0.78). As reported in the Medscape Radiology Lifestyle Report, recent years have witnessed an alarming trend towards worsening burnout among radiology residents [31, 32]. In this regard, potential risk factors included, but were not limited to concerns about making a medical error [31, 32]. As such, given the encouraging results of anxiety reduction when SSTR-RADS is applied (Fig. 1A–C), one may speculate that this framework may reduce such concerns, thereby potentially contributing to a decrease of professional burnout among radiology trainees.
Motivational beliefs of attendees to learn a framework for SSTR-targeted scan interpretation and their rate of clinical implementation were increased already prior to the course. Of note, for AR, respective Cohen’s d was rather low (≥ − 0.28), thereby suggesting only a small impact of the provided training for these categories. Nonetheless, after the course, approval rates for both motivation and clinical implementation remained high (AR, ≥ 3.29 ± 0.58), which further emphasizes that nuclear medicine professionals are eager to learn standardized reporting for SSTR-targeted molecular imaging and are also willing to implement such a system at their departments. In addition, a previous study has already reported on a high interobserver agreement rate, even for less experienced readers, when SSTR-RADS is applied [33]. As such, one may speculate that this or other recently standardized interpretation systems for SSTR-PET/CT will be become more routinely used in multi-center trials [10, 19, 34], which may then allow for better intra- and interinstitutional comparison of scan results [23]. As such, results of the present and previous studies testing SSTR-RADS in different contexts may pave the way for the use of this framework for standardized collection of imaging information for multicenter trials. Nonetheless, prior to a more widespread adoption, further studies are needed, e.g., by correlating framework-based scan findings with histopathological specimen or to test the predictive potential for response to treatment [23]. As such, consensus conferences may arrive at a unified framework, e.g., to apply SSTR-RADS in low-grade NENs and the metabolic grading system in highly proliferative disease [10, 19].
Several limitations have to be considered. First, the number of participants was rather small. Nonetheless, as we chose questionnaires to measure the impact of the training, we considered a medium (0.5) to large effect (0.8) to be of practical relevance [26]. We opted for a pre-post design to achieve higher power to detect training effects [26]. Hence, a power analysis for a two-tailed paired t-test with conventional alpha of 0.05, power of 0.8 and a mean of medium to large effect, i.e., Cohen’s d of 0.65, resulted in the investigated sample size of N = 21. Thus, the number of enrolled participants in our study (N = 22) met this requirement. Also, the post hoc grouping of IR and ER led to disproportional subgroups. This may be misleading because the same effect size may be significant in the larger group but not in the smaller group. However, the effect size of test anxiety for ERs was substantially lower than for IRs. Therefore, we consider it rather unlikely that the observed effect for IRs was concealed by the smaller sample size of the ERs. Nonetheless, future studies should aim for larger and more balanced cohorts having different levels of reading expertise or should explicitly incorporate participant’s experience as independent variable to avoid disproportional groups when sampling. Response rate of the follow-up questionnaire was low and thus, follow-up by both postal mail and e-mail may increase return rates [35]. In addition, the high approval rates among the last three categories (reader’s confidence, motivation, and clinical implementation) could also be partially explained by the acquiescence bias, characterized by a tendency towards always being affirmative regardless of the content of the question [36]. To address this, future studies may also implement inherent quality control questions, e.g., whether the attendees are receptive for such a training on interpreting SSTR-PET/CTs.
Conclusions
A RADS-specific training to interpret SSTR-directed PET/CTs can have a large reduction of test anxiety in less experienced readers. Independent of previous reading experience, motivation of attendees to learn a framework for scan interpretation, their confidence, and their rate of clinical implementation remained stable on a high level throughout the course, thereby suggesting that the impact of the provided training for these categories was low. Nonetheless, given the high pre-/post-interventional approval rates, participants seem to be eager to learn a framework for SSTR-targeted scans, are convinced that such a system increases their level of confidence for interpretation, and are also willing to use RADS at their home institutions. This may allow for a more widespread adoption of this system, e.g., in multicentric trials of NEN patients to collect standardized imaging results for better intra- and interindividual comparison.
References
Park SY, Parihar AS, Bodei L et al (2021) Somatostatin receptor imaging and theranostics: current practice and future prospects. J Nucl Med.
Baum RP, Kluge AW, Kulkarni H et al (2016) [(177)Lu-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide ((177)Lu-DOTATOC) for peptide receptor radiotherapy in patients with advanced neuroendocrine tumours: a phase-II study. Theranostics 6:501–510
Ezziddin S, Reichmann K, Yong-Hing C et al (2013) Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate. Nuklearmedizin 52:170–177
Strosberg J, El-Haddad G, Wolin E et al (2017) Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med 376:125–135
Bodei L, Schoder H, Baum RP et al (2020) Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy. Lancet Oncol 21:e431–e443
Horsch D, Ezziddin S, Haug A et al (2016) Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: a multi-institutional registry study with prospective follow-up. Eur J Cancer 58:41–51
Bodei L, Mueller-Brand J, Baum RP et al (2013) The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 40:800–816
Sabet A, Biersack HJ, Ezziddin S (2016) Advances in peptide receptor radionuclide therapy. Semin Nucl Med 46:40–46
Hope TA, Bergsland EK, Bozkurt MF et al (2018) Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J Nucl Med 59:66–74
Ezziddin S, Adler L, Sabet A et al (2014) Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system. J Nucl Med 55:1260–1266
Cives M, Strosberg J (2017) Treatment strategies for metastatic neuroendocrine tumors of the gastrointestinal tract. Curr Treat Options Oncol 18:14
Werner RA, Weich A, Kircher M et al (2018) The theranostic promise for neuroendocrine tumors in the late 2010s - where do we stand, where do we go? Theranostics 8:6088–6100
Lee CS, Nagy PG, Weaver SJ, Newman-Toker DE (2013) Cognitive and system factors contributing to diagnostic errors in radiology. AJR Am J Roentgenol 201:611–617
West CP, Huschka MM, Novotny PJ et al (2006) Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. JAMA 296:1071–1078
Waite S, Grigorian A, Alexander RG et al (2019) Analysis of perceptual expertise in radiology - current knowledge and a new perspective. Front Hum Neurosci 13:213
https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems. Last Assessed January, 30, 2021.
Tessler FN, Middleton WD, Grant EG et al (2017) ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol 14:587–595
Elsayes KM, Kielar AZ, Elmohr MM et al (2018) White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY) 43:2625–2642
Werner RA, Solnes LB, Javadi MS et al (2018) SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: a proposed standardization framework. J Nucl Med 59:1085–1091
Metser U, Eshet Y, Ortega C, Veit-Haibach P, Liu A, R KSW, (2022) The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors. Nucl Med Commun 43:73–77
Werner RA, Derlin T, Rowe SP, et al. (2020) High interobserver agreement for the standardized reporting system SSTR-RADS 1.0 on somatostatin receptor PET/CT. J Nucl Med.
https://www.eanm.org/esmit/about-2/. Last assessed January, 30, 2021.
Werner RA, Bundschuh RA, Bundschuh L et al (2019) Novel structured reporting systems for theranostic radiotracers. J Nucl Med 60:577–584
Hofman MS, Lau WF, Hicks RJ (2015) Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics 35:500–516
Pintrich PR, De Groot VE (1990) Motivational and self-regulated learning components of classroom academic performance. J Educ Psychol 82:33–40
Cohen J (1988) Statistical power analysis for the behavorial sciences. Lawrence Erlbaum Associates, Publishers 2nd Edition
Spielberger CD, Vagg PR (1995) Test anxiety: a transactional process model. In C. D. Spielberger & P. R. Vagg (Eds.), Series in clinical and community psychology. Test anxiety: theory, assessment, and treatment. Taylor & Francis:3–14.
Zeidner M (1998) Test anxiety: the state of the art. Springer, US
Krispenz A, Gort C, Schültke L, Dickhäuser O (2019) How to reduce test anxiety and academic procrastination through inquiry of cognitive appraisals: a pilot study investigating the role of academic self-efficacy. Front Psychol 10.
Steinmayr R, Crede J, McElvany N, Wirthwein L (2015) Subjective well-being, test anxiety, academic achievement: testing for reciprocal effects. Front Psychol 6:1994
Chetlen AL, Chan TL, Ballard DH et al (2019) Addressing burnout in radiologists. Acad Radiol 26:526–533
Peckham C (2021) Medscape Radiologist Lifestyle Report 2017: race and ethnicity, bias and burnout. https://www.medscapecom/features/slideshow/lifestyle/2017/radiology. Last assessed May, 15, 2021.
Werner RA, Derlin T, Rowe SP et al (2021) High interobserver agreement for the standardized reporting system SSTR-RADS 1.0 on somatostatin receptor PET/CT. J Nucl Med 62:514–520
Chan DL, Pavlakis N, Schembri GP et al (2017) Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance. Theranostics 7:1149–1158
Schaefer DR, Dillman DA (1998) Development of a standard e-mail methodology: results of an experiment. Public Opin Q 62:378–397
Watson D (1992) Correcting for acquiescent response bias in the absence of a balanced scale: an application to class consciousness. Sociological Methods and Research 21:52–88
Acknowledgements
We thank Dr. Dirk Mügge, Adelebsen for his kind statistical advice.
Funding
Open Access funding enabled and organized by Projekt DEAL. TH received funding through the Okayama University “RECTOR” Program and a KAKENHI grant (21K19450) has been provided for TH from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent to Participate
Informed consent has been obtained from all participants.
Conflict of Interest
The authors declare no conflict of interest. The funders were not involved in the study design; in the data interpretation; in the writing of the manuscript, or to publish the results.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Weich, A., Higuchi, T., Bundschuh, R.A. et al. Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers. Mol Imaging Biol 24, 631–640 (2022). https://doi.org/10.1007/s11307-022-01712-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-022-01712-6